{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:01Z","timestamp":1787022421960,"version":"build-2736575974"},"reference-count":52,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej21-0790","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T18:09:41Z","timestamp":1649354981000},"page":"1079-1090","source":"Crossref","is-referenced-by-count":5,"title":["The sellar region as presenting theater for hematologic malignancies\u2014A 17-year single-center experience"],"prefix":"10.1507","volume":"69","author":[{"given":"Sandra","family":"Pekic","sequence":"first","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Manojlovic Gacic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Institute of Pathology, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Antic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toplica","family":"Milojevic","sequence":"additional","affiliation":[{"name":"Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihajlo","family":"Milicevic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Stanimirovic","sequence":"additional","affiliation":[{"name":"Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Doknic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Miljic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Banjalic","sequence":"additional","affiliation":[{"name":"Center for Radiology and Magnetic Resonance Imaging, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Jovanovic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Center for Radiology and Magnetic Resonance Imaging, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvezdana","family":"Jemuovic","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Nikolic Djurovic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Grujicic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u041cilan","family":"Petakov","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Diseases of the Metabolism, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, et al. (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89: 574\u2013580.","DOI":"10.1210\/jc.2003-030395"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Jonkhoff AR, Huijgens PC, Schreuder WO, Teule GJ, Heimans JJ (1993) Hypophyseal non-Hodgkin\u2019s lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol 17: 155\u2013158.","DOI":"10.1007\/BF01050217"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Franceschi E, Frappaz D, Rud\u00e0 R, Hau P, Preusser M, et al. (2020) Rare primary central nervous system tumors in adults: an overview. Front Oncol 10: 996.","DOI":"10.3389\/fonc.2020.00996"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Manojlovic-Gacic E, Rostami E, Karavitaki N, Casar-Borota O (2020) Histopathology of parasellar neoplasms. Neuroendocrinology 110: 740\u2013752.","DOI":"10.1159\/000507084"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Shimon I (2020) Metastatic spread to the pituitary. Neuroendocrinology 110: 805\u2013808.","DOI":"10.1159\/000506810"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 He W, Chen F, Dalm B, Kirby PA, Greenlee JD (2015) Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 18: 159\u2013168.","DOI":"10.1007\/s11102-014-0552-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Cossu G, Brouland JP, La Rosa S, Camponovo C, Viaroli E, et al. (2019) Comprehensive evaluation of rare pituitary lesions: a single tertiary care pituitary center experience and review of the literature. Endocr Pathol 30: 219\u2013236.","DOI":"10.1007\/s12022-019-09581-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Shin DW, Kim JH, Kim YH, Cho YH, Hong SH (2020) Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis. J Neurooncol 147: 339\u2013349.","DOI":"10.1007\/s11060-020-03422-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, et al. (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med 43: 1751\u20131763.","DOI":"10.1007\/s00134-017-4919-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pekic S, Milicevic S, Colovic N, Colovic M, Popovic V (2008) Intravascular large B-cell lymphoma as a cause of hypopituitarism: gradual and late reversal of hypopituitarism after long-term remission of lymphoma with immunochemotherapy. Endocrine 34: 11\u201316.","DOI":"10.1007\/s12020-008-9109-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, et al. (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156: 203\u2013216.","DOI":"10.1530\/eje.1.02326"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2,598 patients. J Clin Endocrinol Metab 96: 1633\u20131641.","DOI":"10.1210\/jc.2011-0168"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zhou X, Zhu H, Yao Y, Lian X, Feng F, et al. (2019) Etiological spectrum and pattern of change in pituitary stalk thickening: experience in 321 patients. J Clin Endocrinol Metab 104: 3419\u20133427.","DOI":"10.1210\/jc.2018-02297"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ogilvie CM, Payne S, Evanson J, Lister TA, Grossman AB (2005) Lymphoma metastazing to the pituitary: an unusual presentation of a treatable disease. Pituitary 8: 139\u2013146.","DOI":"10.1007\/s11102-005-4535-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Tarabay A, Cossu G, Berhouma M, Levivier M, Daniel RT, et al. (2016) Primary pituitary lymphoma: an update of the literature. J Neurooncol 130: 383\u2013395.","DOI":"10.1007\/s11060-016-2249-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Caputo M, Prencipe N, Bisceglia A, Bona C, Maccario M, et al. (2020) Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood. Endocr Pract 26: 1337\u20131350.","DOI":"10.4158\/EP-2020-0286"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Liu JK, Sayama C, Chin SS, Couldwell WT (2007) Extranodal NK\/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg 107: 660\u2013665.","DOI":"10.3171\/JNS-07\/09\/0660"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Yasuda M, Akiyama N, Miyamoto S, Warabi M, Takahama Y, et al. (2010) Primary sellar lymphoma: intravascular large B-cell lymphoma diagnosed as a double cancer and improved with chemotherapy, and literature review of primary parasellar lymphoma. Pituitary 13: 39\u201347.","DOI":"10.1007\/s11102-009-0196-9"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Gupta RK, Saran RK, Srivastava AK, Jagetia A, Garg L, et al. (2017) T cell lymphoblastic lymphoma\/leukemia within an adrenocorticotropic hormone and thyroid stimulating hormone positive pituitary adenoma: a cytohistological correlation emphasizing importance of intra-operative squash smear. Neuropathology 37: 358\u2013364.","DOI":"10.1111\/neup.12375"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Seymour M, Robertson T, Papacostas J, Morris K, Gillespie J, et al. (2021) A woman with visual loss, amenorrhoea and polyuria: the first reported case of nodular lymphocyte-predominant Hodgkin lymphoma presenting with hypopituitarism. Endocrinol Diabetes Metab Case Rep 2021: 20-0100.","DOI":"10.1530\/EDM-20-0100"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zahedi M, Hizomi Arani R, Tohidi M, Haghighi S, Mehrpour M, et al. (2020) Nasopharyngeal B-cell lymphoma with pan-hypopituitarism and oculomotor nerve palsy: a case report and review of the literature. BMC Endocr Disord 20: 163.","DOI":"10.1186\/s12902-020-00644-y"},{"key":"22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood.V79.9.2432.2432","volume":"79","author":"WF Kern","year":"1992","unstructured":"22 Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, et al. (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79: 2432\u20132437.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Naito K, Suzuki S, Ohwada C, Ishiwata K, Ruike Y, et al. (2021) ICAM1-negative intravascular large B-cell lymphoma of the pituitary gland: a case report and literature review. AACE Clin Case Rep 7: 249\u2013255.","DOI":"10.1016\/j.aace.2021.01.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Munawar K, Nayak G, Fatterpekar GM, Sen C, Zagzag D, et al. (2020) Cavernous sinus lesions. Clin Imaging 68: 71\u201389.","DOI":"10.1016\/j.clinimag.2020.06.029"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Antic A, Smiljanic M, Bila J, Jankovic S, Todorovic M, et al. (2012) Hypothalamic dysfunction in a patient with primary lymphoma of the central nervous system. Neurol Sci 33: 387\u2013390.","DOI":"10.1007\/s10072-011-0726-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kenchaiah M, Hyer SL (2011) Diffuse large B-cell non Hodgkin\u2019s lymphoma in a 65-year-old woman presenting with hypopituitarism and recovering after chemotherapy: a case report. J Med Case Rep 5: 498.","DOI":"10.1186\/1752-1947-5-498"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Takao K, Tani A, Suwa T, Kuwabara-Ohmura Y, Nonomura K, et al. (2021) Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report. BMC Endocr Disord 21: 13.","DOI":"10.1186\/s12902-020-00675-5"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 B\u00fchring U, Herrlinger U, Krings T, Thiex R, Weller M, et al. (2001) MRI features of primary. Central nervous system lymphomas at presentation. Neurology 57: 393\u2013396.","DOI":"10.1212\/WNL.57.3.393"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Tsang M, Cleveland J, Rubenstein JL (2020) On point in primary CNS lymphoma. Hematol Oncol 38: 640\u2013647.","DOI":"10.1002\/hon.2761"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Zacharia TT, Law M, Naidich TP, Leeds NE (2008) Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 18: 411\u2013417.","DOI":"10.1111\/j.1552-6569.2007.00231.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Morita K, Nakamura F, Kamikubo Y, Mizuno N, Miyauchi M, et al. (2012) Pituitary lymphoma developing within pituitary adenoma. Int J Hematol 95: 721\u2013724.","DOI":"10.1007\/s12185-012-1075-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Ban VS, Chaudhary BR, Allinson K, Santarius T, Kirollos RW (2017) Concomitant primary CNS lymphoma and FSH-pituitary adenoma arising within the sella. Entirely coincidental? Neurosurgery 80: E170\u2013E175.","DOI":"10.1093\/neuros\/nyw003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ravindra VM, Raheja A, Corn H, Driscoll M, Welt C, et al. (2017) Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report. J Neurosurg 126: 1725\u20131730.","DOI":"10.3171\/2016.5.JNS16828"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Abushamat LA, Kerr JM, Lopes BS, Kleinschmidt-DeMarters BK (2019) Very unusual sellar\/suprasellar region masses: a review. J Neuropathol Exp Neurol 78: 673\u2013684.","DOI":"10.1093\/jnen\/nlz044"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Krisht K, Palmer CA, Couldwell WT (2013) Combined chronic lymphocytic leukemia and prolactinoma: a rare occurrence in a patient presenting with pituitary apoplexy. J Neurosurg 119: 924\u2013928.","DOI":"10.3171\/2013.4.JNS122041"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Harrup R, Pham M, McInerney G (2016) Acute myeloid leukemia with diabetes insipidus and hypophyseal infiltration. Asia Pac J Clin Oncol 12: e350\u2013e351.","DOI":"10.1111\/ajco.12257"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Pirimoglu B, Ogul H, Ozkorucu-Yildirgan D, Keskin-Yildirim Z, Kantarci M (2018) Hypophyseal involvement of acute lymphoblastic leukemia. World Neurosurg 120: 530\u2013531.","DOI":"10.1016\/j.wneu.2018.09.069"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Bardin M, Ritchie D, McLachlan R, Yates CJ (2019) Acute myeloid leukaemia presenting with diabetes insipidus. Intern Med J 49: 785\u2013788.","DOI":"10.1111\/imj.14312"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Faje A (2020) Chronic lymphocytic leukemia, a rare cause of pituitary stalk thickening. Clin Case Rep 8: 1319\u20131320.","DOI":"10.1002\/ccr3.2875"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Fridlyand DM, Keller FG, Sabnis HS, Patterson BC, Gadde JA, et al. (2020) Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor. Pediatr Hematol Oncol 37: 438\u2013444.","DOI":"10.1080\/08880018.2020.1751754"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41 Barcos M, Lane W, Gomez GA, Han T, Freeman A, et al. (1987) An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 60: 827\u2013837.","DOI":"10.1002\/1097-0142(19870815)60:4<827::AID-CNCR2820600419>3.0.CO;2-A"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 M\u00fcller CI, Engelhardt M, Laubenberger J, Kunzmann R, Engelhardt R, et al. (2002) Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7. Eur J Haematol 69: 115\u2013119.","DOI":"10.1034\/j.1600-0609.2002.02763.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Cull EH, Watts JM, Tallman MS, Kopp P, Frattini M, et al. (2014) Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature. Leuk Lymphoma 55: 2125\u20132129.","DOI":"10.3109\/10428194.2013.869327"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 L\u00ea HH, Lengel\u00e9 JP, Henin M, Toffoli S, Mineur P (2021) Diabetes insipidus and acute myeloid leukemia harboring monosomy 7: report of two cases and literature review. Acta Clin Belg 76: 132\u2013135.","DOI":"10.1080\/17843286.2019.1660024"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Lavabre-Bertrand T, Bourquard P, Chiesa J, Berth\u00e9as MF, Lefort G, et al. (2001) Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity? Eur J Haematol 66: 66\u201369.","DOI":"10.1034\/j.1600-0609.2001.00346.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Silverstein A, Doniger DE (1963) Neurologic complications of myelomatosis. Arch Neurol 9: 534\u2013544.","DOI":"10.1001\/archneur.1963.00460110102011"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Sinnott BP, Hatipoglu B, Sarne DH (2006) Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report &amp; literature review. Pituitary 9: 65\u201372.","DOI":"10.1007\/s11102-006-8281-9"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 DiDomenico J, Ampie L, Choy W, Lamano JB, Oyon DE, et al. (2018) Sellar plasmacytomas masquerading as pituitary adenomas: a systematic review. J Clin Neurosci 50: 20\u201323.","DOI":"10.1016\/j.jocn.2018.01.022"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49 Hage M, Kamenick\u00fd P, Chanson P (2019) Growth hormone response to oral glucose load: from normal to pathological conditions. Neuroendocrinology 108: 244\u2013255.","DOI":"10.1159\/000497214"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50 Pekic S, Stojanovic M, Popovic V (2022) Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? Endocrine Oncology 2: R1\u2013R13.","DOI":"10.1530\/EO-21-0033"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, et al. (2002) Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor. Blood 100: 3925\u20133929.","DOI":"10.1182\/blood-2002-05-1406"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Bieghs L, Brohus M, Kristensen IB, Abildgaard N, B\u00f8gsted M, et al. (2016) Abnormal IGF-binding protein profile in the bone marrow of multiple myeloma patients. PLoS One 11: e0154256.","DOI":"10.1371\/journal.pone.0154256"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/9\/69_EJ21-0790\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:23:17Z","timestamp":1715217797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/9\/69_EJ21-0790\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej21-0790","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ21-0790"}}